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Introduction
Atrioventricular Septal Defects (AVSD) represent 7.4% of 
congenital heart defects [1]. Their morphologic features  are 
usually classified as  partial, intermediate and complete form 
in the partial form, a large defect of the Atrial Septum Primum 
(ASD) is present high above two separate atroventricular valves, 
the left one showing  three leflets with a commissure pointing 
towards the inlet ventricular septum; in the intermediate form, 
besides the defects described above, a small portion of the inlet 
ventricular septum is absent (scooped-out) and this results in a 
small communication between the ventricles below the level of 
apposition of the avtrioventricular valves. In the complete form, 
a large portion of the inlet septum is scooped-out, allowing for a 
wide interventricular septal communication. Moreover, a single 
atrioventricular valve is present, guarding the common inlet to 
the ventricles.
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Abstract
Atrioventricular Septal Defects (AVSD) account for 7.4% of Congenital Heart Defects 
(CHD). They may occur in isolation, with a narrow spectrum of age at presentation 
and prognosis, or in association with other intracardiac malformations:  here 
symptoms and needs for treatment vary considerably.  Moreover, their frequent 
association with abnormal genetic disorders, such as Trisomy 21 or Heterotaxy, 
further complicates the task of surgical treatment. Analysing the data is seemingly 
complex: some associations are exceedingly rare, while in other more common 
morphologies, the approach is variable and controversial. Although results   have 
greatly improved in the last decades, early and late survival remains suboptimal, 
sometimes poor. Early mortality greatly varies, along with complexity of 
pathophysiology and repair, from 5% to over 30%.  The dilemma between high 
operative risk and palliation of the univentricular type is at times daunting.  The 
possibility of surgical cure is discussed according to surgical options but the 
frequent need for reintervention makes hope elusive. Late survival greatly differs, 
from 45% to 80% at 5-year follow-up. It is hardly surprising, in the western type 
of society, that prenatal diagnosis should result in a high rate of termination of 
pregnancy. This holds particularly true when a chromosomal abnormality is also 
identified.
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Well-known is the   variable prevalence of associated   trisomy 
21 (Down Syndrome, DS), other genetic syndromes,  such as 
Ellis –Van Crefeld, Holt Oram, Noonan, Smith-Lemli-Opitz, Van 
der Woude, Brachmann-de Lange, Goldenhar, Schizel-Giedion, 
Townes-Brocks and  defect associations such as VACTERL and 
CHARGE (Figure 1) [1]. 
Surgical repair dates back to the early years of cardiac surgery 
and results have steadily improved. 
Atrioventricular septal defects in association with other 
intracardiac malformations (complex forms of AVSD) represent 
a much smaller  percentage of live births, especially in older 
surgical series (Figure 2) [2];  their time of presentation, clinical 
status and possibility of surgical repair greatly differ and so does 
survival and quality of life.   Rare occurrence combines with 
limited data in the medical literature.
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AVSD with Cono-Truncal Anomalies
1. AVSD and Tetralogy of Fallot (ToF)
2. AVSD with Double Outlet Right ventricle  (DORV) + 
Pulmonary Stenosis
3. AVSD with Truncus Arteriosus (TA)
4. AVSD with Transposition of the Great Arteries (TGA)
AVSD with ToF
This rare anomaly (5-10% of all AVSD) is frequently associated 
with DS (60-90% of cases in surgical series).  It is the most 
common cause of cyanosis in patients in the AVSD spectrum 
[3], due to an infundibular and/or pulmonary valve obstruction. 
The ventricular septal defect extends to the subaortic area. 
The AVSD is almost exclusively of the type C in Rastelli’s 
classification. A palliative procedure may be necessary in 
symptomatic neonates or small infants, in view of the complexity 
of complete repair; unfortunately, these procedures may 
result in increased dysfunction of the common AV valve and a 
high early mortality.  Complete repair involves the placement 
of a large “comma-shaped” intraventricular patch through a 
transatrial-transpulmonary [4] or transatrial-transventricular 
surgical approach. Septation of the atria is usually performed 
by a second patch, but some surgeons favour a single-patch 
repair. In recent years, elective repair within the first year of 
life had been performed with a moderate operative risk (4-
9%) [3]. Two-stage and single-stage repair   were compared by 
Vitanova [5] and found to achieve similar results  of survival at 
10 years from repair (78% vs. 83%);  freedom from reoperation 
for left AV valve regurgitation  was also similar (73% vs. 71%). A 
moderate (or more) left AV valve regurgitation before repair was 
a risk factor for valve reintervention. Survival at 15 years from 
surgery varies from 70 to 90% in surgical series [3].  Preservation 
of left AV valve function and right ventricular function are crucial 
in determining long-term morbidity and mortality. Incidence 
of reoperation, for repair or replacement of the left AV, valve 
varies from 5 to 30% [6]. Longer follow-up intervals show a 
constant attrition rate in freedom from reoperation. Great 
emphasis is placed on the reduction of RV damage at repair 
[4,7]; transatrial/transpulmonary repair is widely favoured, 
with minimal transannular patch or a valve-sparing operation. 
The possibility of regurgitant pulmonary and tricuspid valves in 
association, is obviously highly detrimental. Sullivan [8] analysed 
a series of patients with Down Syndrome and ToF or AVSD/ToF, 
who required transannular patch repair [9,10]. They exhibited 
an earlier need for a Pulmonary Valve Replacement (PVR) than 
patients with normal chromosomes did; in a 59-months median 
followup interval, incidence of PVR was 34% vs. 18%,   (p=0.03) 
respectively. A degree of pulmonary hypertension is presumed to 
be a contributory factor; in their series, PVR was more frequent 
in patients with AVSD/ToF than in those with isolated ToF (41 vs. 
18%, p=0.02).
AVSD with DORV
This association represents only 5-8% of all AVSD. A large 
infundibular extension (subaortic or subpulmonary) of the 
ventricular component of the AVSD is present; the aorta is 
estimated to take origin from the right ventricle with more 
than 90% of its annulus (Figure 3). The pulmonary pathway 
may be obstructed. The AVSD morphology most often recalls 
type C of Rastelli classification, but the common valve may be 
Figure 1 Prevalence of genetic disorders in the spectrum of 
atrioventricular septal defects.
Figure 2 Atrioventricular septal defects and associated anomalies. 
Note the absence of “unbalanced Atrioventricular septal 
defect” as a treatable defect in this data from 1982.
Figure 3 Complete form of atrioventricular septal defect 
associated with double-outlet right ventricle. 
Echocardiographic subcostal view showing the great 
arteries, which are side-by-side and in parallel in their 
relationship, and the common atrioventricular valve. 
PA: pulmonary artery; Ao: aorta; CV: common valve.
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anatomically bizarre; besides, either ventricular mass may be 
underdeveloped. The genetic asset of these patients is often 
normal: association with DS is exceedingly rare, while the most 
common genetic anomaly is that of heterotaxy syndrome [11]. 
Early presentation often requires a palliative procedure, either a 
systemic to pulmonary shunt to relief deep cyanosis or pulmonary 
artery banding to reduce pulmonary overcirculation. Anatomical 
repair was reported anecdotically since the mid-seventies, 
sometimes requiring a double-patch ventricular septation. 
Recently, larger series appeared in the literature. Analysis of 
these results is complicated by two factors:  1) some series 
include patients with AVSD/DORV or ToF; 2) other series report 
different approaches, such as anatomic repair (biventricular) and 
Fontan-type palliation/repair. Good results (no early mortality) 
with anatomic repair were reported in 16 selected AVSD/DORV 
patients by Devaney [12].  Ong [6] described a mixed population 
of 44 patients (22 with DORV) with early mortality of 8.3%; In 
the followup period, there were several reoperations, most of 
which were due to left AV valve dysfunction. By the Kaplan-
Meier method, survival was 76% at 10 years, with 55% freedom 
from reoperation at same interval.  In another mixed series 
[13], two-ventricle repair was possible in 35 patients, while 38 
received a Fontan-type repair. Early mortality was similar (31% 
vs. 34%).  The Kaplan-Meier survival at 5 years was 77% and 79%, 
respectively, and freedom from reintervention 85% and 91%. 
A repair performed before 1990 and a significant preoperative 
common AV valve insufficiency were univariate risk factors for 
death at surgery. In a selected series of 83 patients [11], only 8 of 
whom received a two-ventricle repair, 5-year survival was 81%. 
Neonatal presentation, associated heterotaxy (in particular Total 
Anomalous Pulmonary Venous Connection [TAPVC]) and severe 
preoperative common AV valve insufficiency were significant risk 
factors for early death. The considerable variability of anatomic 
features in this group of patients certainly calls for an age-
dependent, individualised approach and for a careful evaluation 
of different strategies. Reinterventions,   inherent to the 
malformation (a common AV valve) and to surgical choices (use 
of right ventricle–to-pulmonary artery [RV-PA] valved conduits.) 
must be anticipated.
AVSD with TA
This exceptional association has been mostly reported in 
pathology specimens. Two cases, successfully repaired, date back 
to 1994 [14] and 1997 [15]. Repair involved atrial and ventricular 
septation, division of pulmonary artery stump from the ascending 
aorta and placement of a RV-PA conduit. In the second case, 
TAPVC was present and required repair. In both cases, a trifoliate 
morphology the left AV valve was maintained.  These patients 
were operated on at 18 days and 8 months of age respectively 
and will require reoperation(s) to replace their first conduit. 
Two further patients, one of whom with prenatal diagnosis [16], 
were associated with Down’s syndrome and heterotaxy [17] and 
were not treated surgically. A recent report [18] describes two 
cases of associated TA with AVSD and left ventricular hypoplasia. 
This complicated anomaly required a real surgical tour-de-
force, starting with bilateral pulmonary artery banding and a 
second stage with division of the common trunk, debanding, 
extensive pulmonary artery reconstruction and bidirectional 
cavopulmonary anastomosis (BCPA). Both patients did well and 
await completion of this Single-Ventricle (SV) palliation. Their 
ultimate outcome remains, nevertheless, uncertain.
AVSD with TGA
This association represents 2-3% of all AVSD. It may be complicated 
by subpulmonary obstruction (left ventricular obstruction). In the 
first reported repair, Gonzalez-Lavin [19] utilized a Fontan type 
repair (right atrial to pulmonary artery valved conduit) and atrial 
septation; the common AV valve was left intact. The second 
attempt [20] was a biventricular repair by a Mustard intra-atrial 
baffle, ventricular septation and a left ventricle (LV) to-PA valved 
conduit. Both patients survived. In the following surgical era, the 
arterial switch operation was employed, together with AVSD 
repair [21-24]. Some patients had been previously treated with a 
pulmonary artery banding; the association with heterotaxy (left 
isomerism) and complex venous return required an intraatrial 
baffle procedure as well [24].  All these anecdotical reports 
did well at surgery.  Complications related the chosen surgical 
strategy (Fontan repair, intraatrial baffles and arterial switch 
operation) may occur in the late postoperative period, but data 
is not available.
Unbalanced AVSD and Single Ventricle 
(SV) Physiology
The term “unbalanced AVSD” (10-25% of all AVSD cases) 
pertains to a cardiac morphology where one of the ventricles 
has a reduced inlet portion and cavity size; the other ventricle 
is then termed “dominant”.  Because a biventricular repair is 
the ideal solution for an AVSD, the definition of small ventricle 
(that is, unable to manage cardiac output) has been the source 
of considerable debate. Proposed metric parameters, calculated 
by echocardiography, include:   atrioventricular valve index [25] 
(AVVI), right ventricular/left ventricular inflow angle [26], left 
ventricular inflow index [27] (LVII) and indexed ventricular septal 
defect [28].  Staged surgery aiming at promoting ventricular 
growth, by increasing blood flow through the hypoplastic valve, 
has also been proposed [29]. Nevertheless, borderline patients 
are encountered, and this may explain why the treatment of this 
condition remained challenging for decades and contemporary 
results, although improved, are still suboptimal.
AVSD with left ventricular dominance (or right 
ventricular hypoplasia)
AVSD with left ventricular (LV) dominance is very uncommon and 
has a strong correlation to DS (Figures 4 and 5). Other   genetic 
anomalies are very rare.  In a multi-institutional study of 305 
infants with AVSD [30], left dominance  was found in 8, on the 
basis of AVVI.  Six had biventricular repair with 1 death, and 2 
had intermediate surgery, with 1 death. Strategies to counteract 
right ventricular (RV) hypoplasia were a calibrated residual ASD 
or a bidirectional cavopulmonary anastomosis. De Oliveira [31] 
reported that in 38 patients, 32 underwent biventricular repair; 
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AVVI and RV/LV length ratio were employed in the surgical 
decision making. There were 3 deaths (9%) in this group and 1 
(17%) in the single ventricle (SV) palliation group. Two patients 
in the biventricular group were reoperated on to create an ASD 
and survived. The conclusion of this work is that an attempt 
at biventricular repair, with creation of an adjustable ASD is 
justifiable. The authors feel that SV palliation in presence of 
DS   is hazardous, because of inherent (even mildly) elevated 
pulmonary vascular resistance and respiratory problems.  A 
recent report [32] described a successful biventricular repair 
after biventricular palliation (residual ASD or bidirectional 
cavopulmonary anastomosis).
AVSD with right ventricular dominance (or left 
ventricular hypoplasia)
AVSD with right ventricular (RV) dominance is more frequently 
encountered (Figures 6 and 7): there were 50 patients in the 
previously mentioned multi-institutional study [30]. Various 
genetic assets have been reported, including normal kariotype, 
DS, heterotaxy and others syndromes. As the hypoplasia concerns 
the systemic ventricle, the identification of cutpoints with the 
available diagnostic methods is of uppermost relevance. A value 
of AVVI ≤ 0.67, RV/LV inflow angle (systolic) ≤ 114°, combined 
AVVI>0.41 with LVII <0.55 were considered to indicate/ predict 
SV Palliation [26].  Nevertheless, common AV valve  flow direction 
[27], a significant AV valve regurgitation and  presence of a large 
ventricular septal defect [25] are believed to  also influence the 
decision making process. In five reported series [25-27,30,33] 
biventricular repair was deemed possible in 86 patients, but 16 did 
not survive (19% mortality); 108 underwent SV staged palliation, 
with 40 deaths (mortality =37%).  The subsequent course, in both 
groups, was complicated by the need of reoperation, usually due 
to left/common AV valve dysfunction.  Limited information is 
available on medium-term survival; in Arunamata’s [26] series, 
Figure 4 Echocardiogaphic image of a case of AVSD with left 
dominance: left panel: + symbols indicate the entire 
common AV valve and x the central limit of it.
Figure 5 AVSD with left dominance: the right component of the 
common AV valve is interposed between the x and 
pointed square symbols. Note the extreme reduction of 
right ventricular chamber.
Figure 6 AVSD with right dominance; the black asterisk indicates 
the ventricular septum. Upper panel: subxyphoid four-
chamber view. Lower panel: subxiphoid short axis view. 
Severe left ventricular hypoplasia. RA=right atrium, 
LA=left atrium, RV=right ventricle, LV=left ventricle.
Figure 7 Complete form of atrioventricular septal defect with 
left ventricular hypoplasia; four-chamber view. RA=right 
atrium, LA=left atrium, RV=right ventricle, LV=left 
ventricle.
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the seven-year survival in the whole group was 76%. Owens [33] 
reported an overall survival of 44% at 5 years of follow-up. In these 
patients, SV palliation appears to carry a worse prognosis than in 
cases with Hypoplastic left heart syndrome, probably due to the 
frequent malfunction of the common AV valve. While conversion 
from a failing biventricular repair to SV palliation is likely doomed 
to fail [34], the opposite pathway has been explored in recent 
years: conversion from SV palliation to biventricular repair [35]. In 
an initial series of 16 symptomatic patients at different stages of 
SV palliation, conversion to biventricular repair was considered, 
on the basis of echocardiographic 2-D and 3-D evaluation and 
MRI measurement of ventricular volumes. There was one early 
and one late death; 8 patients required reoperation. Most of 
these patients had genetic abnormalities (DS, heterotaxy) that 
are deemed at high risk for SV palliation. Additional data from 
the same group [36] suggested a lower incidence of need for 
heart transplantation and for catheter-based reinterventions 
with conversion to biventricular repair (complete or staged) than 
with SV palliation.  Herrin reported that hemodynamic data [37] 
are extremely relevant in predicting an adverse outcome when 
a conversion approach is adopted. This strategy has raised a 
considerable debate [38-40]. A recent analysis of SV palliation for 
unbalanced AVSD reported a 25-year survival lower than 60%, 
still better than previously thought [41]. Reoperation for AV 
valve dysfunction remains a common plague in any conceivable 
strategy for these patients. 
The Role of Down Syndrome in the 
Choice of a Surgical Strategy
Persons with Down Syndrome have multiple problems besides 
the high prevalence of CHD. Respiratory illnesses are very 
common in children with DS under the age of 3 years (Watts). 
Upper airways problems (macroglossia, laryngolamalacia, 
choanal stenosis, tracheomalacia, subglottic stenosis) may be 
present and, in combination with hypotonia, cause obstructive 
sleep apnoea (OSA). Recurrent episodes of silent aspiration 
may increase the incidence of respiratory tract infections.  All 
these anomalies and events   negatively affect the indication for 
congenital heart surgery. In particular, the hazard of (even mildly) 
elevated pulmonary vascular resistance has been considered 
a contraindication to univentricular palliation or correction 
(Fontan-type) for patients with DS. This concept was re-evaluated 
in the last decade with better patient selection.  Excellent survival 
at palliation has been achieved when pulmonary vascular 
resistance was low (<3 WUnits/m2) during the first year of life [42-
44]. Nonetheless, an attrition rate (death, unsuitability, failure) 
towards Fontan-type repair of 27.5% at 5 years was described in 
patients with unbalanced AVSD [45]. A large study on congenital 
heart surgery for DS from Japan [46] showed that Fontan-type 
repair was rarely performed and found at high risk (12% early 
mortality). Reports on small series of patients often describe 
surprisingly conflicting results, a fact that confirms the important 
role of selection of low-risk candidates [47,48]. Experience with 
heart transplantation is similarly limited in patients with DS. 
Ethical reasons and organ access limitations have been implied. 
Isolated reports of successful heart trasplantation in patients with 
DS and cardiomyopathy have appeared in the literature in the last 
decade [49,50]. In a nationwide US database, 64 patients (2.1%) 
with chromosomal abnormalities had heart transplantation 
[51], only 5 of whom had DS.  In a group of patients of extreme 
anatomic severity such as unbalanced AVSD, it is likely that the 
option of heart transplantation for a DS patient will have to be 
considered.
Conclusion
In complex forms of AVSD,   the extent of repair is challenging 
and may result in reduced survival in comparison to isolated 
forms. Besides, probability of cure is very low.  Ingenious 
surgical strategies have been developed, in order to reduce 
need for reinvention(s) and late mortality. The common AV 
valve, inherently abnormal, still represents the major source of 
late reintervention and mortality. SV type of palliation carries 
a global risk which is considered by some authors higher than 
with Hypoplastic Left Heart Syndrome. Prenatal diagnosis is 
now a standard of care. The association of DS with a complex 
malformation, for which treatment offers limited results, 
may weigh on the individual parental choice of termination of 
pregnancy. In the western-type society, this trend is indicated 
by the reduction of live-born children with the complete form 
of isolated AVSD, a defect which implies a very low surgical risk. 
Complex forms of AVSD may undoubtedly follow in this path 
[52,53]. 
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